149 related articles for article (PubMed ID: 30661456)
1. Paternal genome rescues mouse preimplantation embryo development in the absence of maternally-recruited EZH2 activity.
Wang H; Paulson EE; Ma L; Ross PJ; Schultz RM
Epigenetics; 2019 Jan; 14(1):94-108. PubMed ID: 30661456
[TBL] [Abstract][Full Text] [Related]
2. H3K27me3 may be associated with Oct4 and Sox2 in mouse preimplantation embryos.
Wu FR; Zhang Y; Ding B; Lei XH; Huang JC; Wang CH; Liu Y; Wang R; Li WY
Genet Mol Res; 2014 Dec; 13(4):10121-9. PubMed ID: 25501223
[TBL] [Abstract][Full Text] [Related]
3. Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells.
Xiong X; Zhang J; Liang W; Cao W; Qin S; Dai L; Ye D; Liu Z
Int J Oncol; 2016 Aug; 49(2):623-8. PubMed ID: 27278257
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Ezh2 In Vitro and the Decline of
Hong F; Zhao M; Zhang L; Feng L
Stem Cells Dev; 2019 May; 28(10):649-658. PubMed ID: 30887911
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism.
Pereira ASA; Amaral MS; Vasconcelos EJR; Pires DS; Asif H; daSilva LF; Morales-Vicente DA; Carneiro VC; Angeli CB; Palmisano G; Fantappie MR; Pierce RJ; Setubal JC; Verjovski-Almeida S
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006873. PubMed ID: 30365505
[TBL] [Abstract][Full Text] [Related]
6. Effect of EZH2 knockdown on preimplantation development of porcine parthenogenetic embryos.
Cai Q; Niu H; Zhang B; Shi X; Liao M; Chen Z; Mo D; He Z; Chen Y; Cong P
Theriogenology; 2019 Jul; 132():95-105. PubMed ID: 31004879
[TBL] [Abstract][Full Text] [Related]
7. EZH2 is essential for development of mouse preimplantation embryos.
Huang XJ; Wang X; Ma X; Sun SC; Zhou X; Zhu C; Liu H
Reprod Fertil Dev; 2014 Oct; 26(8):1166-75. PubMed ID: 24153105
[TBL] [Abstract][Full Text] [Related]
8. Full methylation of H3K27 by PRC2 is dispensable for initial embryoid body formation but required to maintain differentiated cell identity.
Miller SA; Damle M; Kim J; Kingston RE
Development; 2021 Apr; 148(7):. PubMed ID: 33688077
[TBL] [Abstract][Full Text] [Related]
9. Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development.
Erhardt S; Su IH; Schneider R; Barton S; Bannister AJ; Perez-Burgos L; Jenuwein T; Kouzarides T; Tarakhovsky A; Surani MA
Development; 2003 Sep; 130(18):4235-48. PubMed ID: 12900441
[TBL] [Abstract][Full Text] [Related]
10. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
11. The EZH2-PRC2-H3K27me3 axis governs the endometrial cell cycle and differentiation for blastocyst invasion.
Fukui Y; Hirota Y; Aikawa S; Sakashita A; Shimizu-Hirota R; Takeda N; Ishizawa C; Iida R; Kaku T; Hirata T; Hiraoka T; Akaeda S; Matsuo M; Osuga Y
Cell Death Dis; 2023 May; 14(5):320. PubMed ID: 37198149
[TBL] [Abstract][Full Text] [Related]
12. Distinct dynamics and functions of H2AK119ub1 and H3K27me3 in mouse preimplantation embryos.
Chen Z; Djekidel MN; Zhang Y
Nat Genet; 2021 Apr; 53(4):551-563. PubMed ID: 33821005
[TBL] [Abstract][Full Text] [Related]
13. GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells.
Xiong X; Zhang J; Li A; Dai L; Qin S; Wang P; Liu W; Zhang Z; Li X; Liu Z
Cancer Biol Ther; 2020; 21(3):213-222. PubMed ID: 31651209
[TBL] [Abstract][Full Text] [Related]
14. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
Ihira K; Dong P; Xiong Y; Watari H; Konno Y; Hanley SJ; Noguchi M; Hirata N; Suizu F; Yamada T; Kudo M; Sakuragi N
Oncotarget; 2017 Feb; 8(8):13509-13520. PubMed ID: 28088786
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
[TBL] [Abstract][Full Text] [Related]
16. PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome.
Meng TG; Zhou Q; Ma XS; Liu XY; Meng QR; Huang XJ; Liu HL; Lei WL; Zhao ZH; Ouyang YC; Hou Y; Schatten H; Ou XH; Wang ZB; Gao SR; Sun QY
Nat Commun; 2020 Dec; 11(1):6354. PubMed ID: 33311485
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Histone Methyltransferase Inhibitors on the Survival, Apoptosis and Cell Cycle of Raji Cells].
Xiao LR; Hou C; Zheng SJ; Guo B; Chen DN; Yan NH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):305-310. PubMed ID: 31631594
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.
Agarwal P; Alzrigat M; Párraga AA; Enroth S; Singh U; Ungerstedt J; Österborg A; Brown PJ; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
Oncotarget; 2016 Feb; 7(6):6809-23. PubMed ID: 26755663
[TBL] [Abstract][Full Text] [Related]
19. GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1α in human peritoneal mesothelial cells treated with high glucose.
Wang Q; Xu L; Zhang X; Liu D; Wang R
Eur J Pharmacol; 2020 Aug; 880():173076. PubMed ID: 32222493
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells.
Ying L; Yan F; Williams BR; Xu P; Li X; Zhao Y; Hu Y; Wang Y; Xu D; Dai J
Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):58-67. PubMed ID: 28925507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
